N-formylpeptides induce two distinct concentration optima for mouse neutrophil chemotaxis by differential interaction with two N-formylpeptide receptor (FPR) subtypes. Molecular characterization of FPR2, a second mouse neutrophil FPR

N-formylpeptides induce two distinct concentration optima for mouse neutrophil chemotaxis by differential interaction with two N-formylpeptide receptor (FPR) subtypes. Molecular characterization of FPR2, a second mouse neutrophil FPR

Item

http://www.wikidata.org/entity/Q28343567

Q28343567

about

N-arachidonoyl glycine, an abundant endogenous lipid, potently drives directed cellular migration through GPR18, the putative abnormal cannabidiol receptor International Union of Basic and Clinical Pharmacology. LXXIII. Nomenclature for the formyl peptide receptor (FPR) family Cytochalasin B triggers a novel pertussis toxin sensitive pathway in TNF-alpha primed neutrophils Functional characterization of three mouse formyl peptide receptors A novel method for isolation of neutrophils from murine blood using negative immunomagnetic separation Functional and ultrastructural analysis of annexin A1 and its receptor in extravasating neutrophils during acute inflammation MLK3 regulates fMLP-stimulated neutrophil motility.Microfluidic kit-on-a-lid: a versatile platform for neutrophil chemotaxis assays Definition of a Novel Pathway Centered on Lysophosphatidic Acid To Recruit Monocytes during the Resolution Phase of Tissue Inflammation N-Formyl peptide receptor subtypes in human neutrophils activate L-plastin phosphorylation through different signal transduction intermediates.Anti-inflammatory role of the murine formyl-peptide receptor 2: ligand-specific effects on leukocyte responses and experimental inflammation.Characterization of Fpr-rs8, an atypical member of the mouse formyl peptide receptor gene family.Changes in activation states of murine polymorphonuclear leukocytes (PMN) during inflammation: a comparison of bone marrow and peritoneal exudate PMN.Uteroglobin suppresses allergen-induced TH2 differentiation by down-regulating the expression of serum amyloid A and SOCS-3 genes.Involvement of the receptor for formylated peptides in the in vivo anti-migratory actions of annexin 1 and its mimetics Formyl peptide receptors and the regulation of ACTH secretion: targets for annexin A1, lipoxins, and bacterial peptides.The virulence regulator Agr controls the staphylococcal capacity to activate human neutrophils via the formyl peptide receptor 2.Human formyl peptide receptor 2 senses highly pathogenic Staphylococcus aureus Differential contribution of bacterial N-formyl-methionyl-leucyl- phenylalanine and host-derived CXC chemokines to neutrophil infiltration into pulmonary alveoli during murine pneumococcal pneumonia The leukocyte chemotactic receptor FPR1 is functionally expressed on human lens epithelial cells New development in studies of formyl-peptide receptors: critical roles in host defense The major leukocyte chemotactic and activating factors in the mouse gut lumen are not N-formylpeptide receptor 1 agonists.Formyl-methionyl-leucyl-phenylalanine-induced dopaminergic neurotoxicity via microglial activation: a mediator between peripheral infection and neurodegeneration?Intraluminal containment of commensal outgrowth in the gut during infection-induced dysbiosis.Identification of formyl peptides from Listeria monocytogenes and Staphylococcus aureus as potent chemoattractants for mouse neutrophils.Resolvins: Endogenously-Generated Potent Painkilling Substances and their Therapeutic Perspectives.Small-molecule-biased formyl peptide receptor agonist compound 17b protects against myocardial ischaemia-reperfusion injury in mice.Formyl-peptide receptor 2 governs leukocyte influx in local Staphylococcus aureus infections.Regulation of inflammation by members of the formyl-peptide receptor family.Designer cells programming quorum-sensing interference with microbes.A novel antimicrobial peptide acting via formyl peptide receptor 2 shows therapeutic effects against rheumatoid arthritis

P2860

Q21093349-8BDC567C-93CD-4AA3-B4A3-AE99EADB634E Q24652940-56B006A2-44DC-4574-80A8-FBB8F653B076 Q24800189-4E5D1E9B-0548-4728-910A-FE0FB722CEA3 Q28279407-73EEFDC0-9167-4DEC-8306-5168FE9E2472 Q28345272-EB4B9A40-C65A-4F97-A736-EF1EDE3ABAE9 Q28585572-ACC7644B-E22F-4CEE-9808-3F1EEEA7B28B Q30009504-04020F47-049B-4183-A18C-085E5348117D Q30525566-46842DEE-E508-4E10-BC60-6BF45A392BA6 Q30657993-07DDDBFE-9B78-4F53-B31E-7257ED2104E1 Q31011302-A56157D6-3C34-4EEF-828D-E37945A3E63A Q34095174-5C50D92A-10EB-4D10-B9AC-A290610CA9D5 Q34194202-20024DE9-9ED9-465B-9D55-81858C8DCA74 Q34601549-A76B8E94-C080-44B5-909F-622FE57A3E7C Q35768177-E0BB08AC-D2EB-495E-B42B-59BD93B864DF Q35842296-474B752D-2265-4F05-A664-DD45E7E34DA6 Q35844396-D87598FC-1C0D-4A7A-A182-879EE8E0C46D Q36072090-8848CF54-1DAF-4BF8-846E-9464BFBF0C1C Q36157687-47FEDE41-135F-4A0C-96DE-4C63AE0D424B Q36313780-2332728B-D7EB-4E75-8094-D2F8DBBF1E52 Q36418959-D25D9EFE-C5F4-43EE-8F3C-1C4B3B9D0FE4 Q36570742-2DC1D592-B62E-4E0D-A5C0-2186A63E7124 Q36624209-6F38FD44-E6A6-46B4-98FE-1DCBDE122ED0 Q36633062-D7E216A2-5B0B-460A-A4FB-5830924AD75B Q36724806-CAC78547-0BAF-41A8-A868-35BDEAEC7BEB Q37250080-398B3B80-F1E4-4117-BCF7-161880A54F01 Q37362056-D8E9718A-7E62-4502-8461-C90C6D8ACC12 Q37642476-7A188983-8D4C-4AEA-9732-8BE90BAF565E Q38601688-67D5469B-6CA6-4AC7-8C0E-D398D23B3629 Q39423782-6945890C-0C73-460C-939E-CD4EC45D6F55 Q54936236-FB06CBCA-9B5C-49D8-B583-AFE11B2481EB Q57050477-FA613FD7-7433-43FC-8D59-1F98B18B3C0D

P2860

N-formylpeptides induce two distinct concentration optima for mouse neutrophil chemotaxis by differential interaction with two N-formylpeptide receptor (FPR) subtypes. Molecular characterization of FPR2, a second mouse neutrophil FPR

Item

http://www.wikidata.org/entity/Q28343567

description

1999 nî lūn-bûn

@nan

1999 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

1999 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

1999年の論文

@ja

1999年論文

@yue

1999年論文

@zh-hant

1999年論文

@zh-hk

1999年論文

@zh-mo

1999年論文

@zh-tw

1999年论文

@wuu